shenzhen salubris pharmaceuticals co., ltd.-九游会

 shenzhen salubris pharmaceuticals co., ltd.-九游会

deeply engaged in therapeutic area of hypertension and related diseases

following the successfuldevelopment of  innovative drugallisartan isoproxil tablets (xinlitan) for hypertension, we have been developingsacubitril allisartan calcium and two compound preparations, being committed tobringing new drug choices to patients with hypertension. up to date, several genericproducts for treatment of hypertension have received “highly equivalent to theinnovatives” from nampa based on their high quality profiles. 

existing product line

网站地图